Search Results - "Fridman Dror, Anna"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cells by Yehudai‐Resheff, Shlomit, Attias‐Turgeman, Shira, Sabbah, Rawan, Gabay, Tal, Musallam, Raneem, FridmanDror, Anna, Zuckerman, Tsila

    Published in International journal of cancer (01-05-2019)
    “…Hematopoietic progenitors, residing in the bone marrow (BM) niche, are supported by mesenchymal stromal cells (MSCs). Cytogenetic and molecular aberrations in…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Abstract 2846A: CD28 shedding is a novel immune-regulatory mechanism found in cancer patients which directly inhibits anti PD-1 effect by Hakim, Motti, Dror, Anna Fridman, Alishekevitz, Dror, Meilin, Edna, Shilovizky, Orit, Weber, Jeffrey S., Sapir, Yair, Shulman, Avidor, Moshe, Tehila Ben

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Background The interaction between the CD28 receptor and its B7 ligands has a crucial role in the induction of a potent and persistent anti-tumor T…”
    Get full text
    Journal Article
  5. 5

    Donor Cell Leukemia: The Role of Recipient Microenvironment by Yehudai-Reshef, Shlomit, Oron, Barak, Moskovitz, Yoni, Gabay, Tal, Fridman-Dror, Anna, Sabah, Rawan, Kaushansky, Nathali, Zuckerman, Tsila, Shlush, Liran I.

    Published in Blood (29-11-2018)
    “…Acute myeloid leukemia (AML) is one of the extreme outcomes of age-related clonal hematopoiesis (ARCH). In recent years, data on differences between pre-AML…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Abstract 654: CD28 shedding is a novel resistance mechanism to anti PD-1 therapy by Hakim, Motti, Dror, Anna Fridman, Gabay, Tal Shahar, Alishekevitz, Dror, Meilin, Edna, Mandel, Ilana, Sapir, Yair, Shulman, Avidor, Moshe, Tehila Ben

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract Background: Resistance mechanisms to anti-PD1 therapy remain poorly understood. Studies have implicated that efficient anti-PD1 therapy relies…”
    Get full text
    Journal Article